PreActiv secures £500K Pre-Seed investment led by Exceptional Ventures
Summary
It reduces the risk of complications by 50 percent and shortens hospital stays by an average of two days, alongside improving a patients overall long term health.Given these benefits it is unsurprising that NHS England has mandated trusts to incorporate prehabilitation into their care protocols as part of their new perioperative guidelines. As a highly cost-effective prehabilitation option, they have become the ideal solution to meet NHS Englands latest guidelines.PreActivs groundbreaking platform has garnered impressive interest, securing Exceptional Ventures as the lead investor. PreActivs integration of patient data, support networks, and educational resources makes it a promising innovation in improving surgical outcomes and long-term health.Joining Exceptional Ventures with follow-on funding is Europes leading early stage tech for good VC, Bethnal Green Ventures alongside Angel Academe and a group of experienced angel investors.PreActiv co-founder Dr. Alec Snow, a consultant anaesthetist and ICU physician, said, We are excited by the success of our pre-seed raise. Our goal within the next year is to become the market leads in prehabilitation, supplying healthcare providers with the tools they need to optimise patient health whilst reducing costs and pressure on their servicesAlongside closing their pre-seed investment round, the award winning company is also in the final weeks of their clinical trial, in collaboration with Bath University and Royal United Hospitals Bath.Co-founder and Women in Innovation winner, Dr Rebecca Allam added: PreActivs platform is already demonstrating transformative results. We look forward to releasing the final clinical data within the coming months.An innovative digital platform that harnesses technology to create dynamic, individualised prehabilitation programmes to physically optimise patients for surgery.